Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.

Autor:	Xie, W.1 (AUTHOR), Ravi, P.1 (AUTHOR), Buyse, M.2,3 (AUTHOR), Halabi, S.4 (AUTHOR), Kantoff, P.5 (AUTHOR), Sartor, O.6 (AUTHOR), Soule, H.7 (AUTHOR), Clarke, N.8 (AUTHOR), Dignam, J.9 (AUTHOR), James, N.10 (AUTHOR), Fizazi, K.11 (AUTHOR), Gillessen, S.12,13 (AUTHOR), Mottet, N.14 (AUTHOR), Murphy, L.15 (AUTHOR), Parulekar, W.16 (AUTHOR), Sandler, H.17 (AUTHOR), Tombal, B.18 (AUTHOR), Williams, S.19 (AUTHOR), Sweeney, C.J.1,20 (AUTHOR) Christopher.sweeney@adelaide.edu.au
Zdroj:	Annals of Oncology. Mar2024, Vol. 35 Issue 3, p285-292. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu